Arena Sees Phase III Path For Etrasimod After Atopic Dermatitis Miss

Analysts Agreed The S1P Receptor Modulator Should Advance

 
• By Mandy Jackson
  
Pathway in the garden outdoor, forward stepping stones or pebbled in the grass lawn.
Arena identified a path forward for etrasimod in atopic dermatitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D